Valeant CEO Seeks Up To 50 Acquisitions, Many In Emerging Markets
This article was originally published in PharmAsia News
Executive Summary
Canada's Valeant Pharmaceuticals International is seeking acquisitions in Southeast Asia, including China, and in Latin America, the Middle East and Russia, up to 50 in its quest to be one of the world's top five drug makers.